Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $50.0K | $0 | $478.0K | $489.8K | $838.6K |
| Cost of revenue | $0 | $0 | $0 | $0 | $1.2K | $180.7K | $133.7K | $155.7K |
| Gross profit | −$3.6K | $0 | $0 | $50.0K | −$1.2K | $297.3K | $356.1K | $682.9K |
| Gross margin | — | — | — | 100.0% | — | 62.2% | 72.7% | 81.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$76.6K | −$94.2K | −$147.6K | $7.4K | −$270.0K | −$1.4M | −$863.0K | −$222.0K |
| EBITDA | −$12.8K | −$21.9K | −$147.6K | $47.5K | −$269.0K | −$1.2M | −$714.0K | −$133.0K |
| Net income | −$89.4K | −$116.0K | −$148.2K | $29.5K | −$467.0K | −$1.8M | −$4.8M | −$1.2M |
| Net margin | — | — | — | 58.9% | — | -381.4% | -971.2% | -148.1% |
| EPS (diluted) | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 | -0.03 | -0.01 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds HQDA.
No tracked institution reports a position in HQDA as of their last filing.
No one on the platform has traded HQDA yet.
| $20M |
| — |
| OCELOrganicell Regenerative Medicine, Inc. | $2.74 | -0.27% | $20M | — |
| RDTCFRapid Dose Therapeutics Corp. | $0.01 | +0.00% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.